Singapore markets open in 7 hours 36 minutes
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,050.61 +32.22 (+0.64%) Dow
38,127.04 +223.75 (+0.59%) Nasdaq
15,780.63 +175.15 (+1.12%) Bitcoin USD
59,175.18 +2,227.37 (+3.91%) CMC Crypto 200
1,272.87 +2.13 (+0.17%)
Theravance Biopharma, Inc. (TBPH)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 01:24PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 429.27M |
| Enterprise value | 376.00M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 8.51 |
| Price/book (mrq) | 2.02 |
| Enterprise value/revenue | 6.55 |
| Enterprise value/EBITDA | -8.81 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.35 |
| 52-week change 3 | -21.35% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 11.98 |
| 52-week low 3 | 8.21 |
| 50-day moving average 3 | 9.07 |
| 200-day moving average 3 | 9.60 |
Share statistics
| Avg vol (3-month) 3 | 403.19k |
| Avg vol (10-day) 3 | 510.71k |
| Shares outstanding 5 | 48.56M |
| Implied shares outstanding 6 | 48.56M |
| Float 8 | 15.86M |
| % held by insiders 1 | 14.51% |
| % held by institutions 1 | 103.33% |
| Shares short (15 Apr 2024) 4 | 6.43M |
| Short ratio (15 Apr 2024) 4 | 14.32 |
| Short % of float (15 Apr 2024) 4 | 26.03% |
| Short % of shares outstanding (15 Apr 2024) 4 | 13.24% |
| Shares short (prior month 15 Mar 2024) 4 | 8.4M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -96.11% |
| Operating margin (ttm) | -35.53% |
Management effectiveness
| Return on assets (ttm) | -6.73% |
| Return on equity (ttm) | -16.86% |
Income statement
| Revenue (ttm) | 57.42M |
| Revenue per share (ttm) | 1.04 |
| Quarterly revenue growth (yoy) | 19.90% |
| Gross profit (ttm) | N/A |
| EBITDA | -53.19M |
| Net income avi to common (ttm) | -55.19M |
| Diluted EPS (ttm) | -1.00 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 102.43M |
| Total cash per share (mrq) | 2.13 |
| Total debt (mrq) | 49.16M |
| Total debt/equity (mrq) | 23.08% |
| Current ratio (mrq) | 5.39 |
| Book value per share (mrq) | 4.43 |
Cash flow statement
| Operating cash flow (ttm) | -27M |
| Levered free cash flow (ttm) | -13.89M |
© 2024 Yahoo. All rights reserved.